Evidence map›Paper›PMID 39810622›Full record

ArticleThe Laryngoscope2025

Comparing Otolaryngology Subspecialties' Changes in Medicare Reimbursement From 2013 to 2024.

Alexander Dorius, Wesley Allen, Carson Bateman, Joshua Demke, Winslo Idicula

Abstract readComparative Study
In one paragraph

Article in The Laryngoscope, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander DoriusTexas Tech University Health Sciences Center, School of Medicine, Lubbock, Texas, U.S.A.ORCID 0000-0002-1150-0372
Wesley AllenSpencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, U.S.A.
Carson BatemanSpencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, U.S.A.
Joshua DemkeDepartment of Otolaryngology, Texas Tech University Health Sciences Center, Lubbock, Texas, U.S.A.
Winslo IdiculaDepartment of Otolaryngology, Texas Tech University Health Sciences Center, Lubbock, Texas, U.S.A.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIdentify differences in Medicare reimbursement changes for general otolaryngology, pediatric otolaryngology, head and neck oncology, laryngology, rhinology, otology, facial plastic and reconstructive surgery, and sleep surgery subspecialties from 2013 to 2024.

methodsSubspecialty-based procedures' facility prices and relative value units (RVUs) were sourced from the Centers for Medicare & Medicaid Services' Physician Fee Schedule. Prices were adjusted for inflation, and the average percent change in facility price and RVUs for each subspecialty was calculated. Each subspecialty's average inflation-adjusted, facility price change was compared to general otolaryngology using t-tests, and differences between subspecialties were assessed using Dunn's test.

resultsFrom 2013 to 2024, general otolaryngology's average percent change was -29.9% and significantly differed from facial plastic and reconstructive surgery (-26.4% [-5.5 to -0.7%]; p = 0.011) and sleep surgery (-23.7% [-19.2 to -2.2%]; p = 0.016). Rhinology (-32.5% [-1.3 to 6.1%]), otology (-30.2% [-6.5 to 7.6%]), laryngology (-29.3 [-4.2 to 2.1%]), head and neck (-27.4% [-5.7 to 0.2%]), and pediatric otolaryngology (-25.8% [-14.6 to 3.8%]) also decreased drastically but were not significantly different from general otolaryngology. For the multiple comparisons test, rhinology was statistically different from sleep surgery and facial plastic and reconstructive surgery.

conclusionGeneral otolaryngology and rhinology were more negatively affected due to changes in work and practice expense RVUs. Universal decreases were due to inflation and legislative reductions to the conversion factor. Medicare's budget constraints, potential effects on access to otolaryngology services, and continuing inflation warrant lobbying efforts to address these changes to maintain financial viability. LEVEL OF EVIDENCE: NA Laryngoscope, 135:1950-1957, 2025.

Indexed as

Insurance, Health, ReimbursementMedicareOtolaryngologyHumansUnited Stateshealth care economicsMedicare reimbursementotolaryngology fellowship

Identifiers

PMID39810622
PMCPMC12082009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.